- Home
- ACET vs FTCI Comparison
ACET vs FTCI Comparison
Compare ACET & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- FTCI
- Stock Information
- Founded
- ACET 1947
- FTCI 2017
- Country
- ACET United States
- FTCI United States
- Employees
- ACET N/A
- FTCI N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- FTCI Semiconductors
- Sector
- ACET Health Care
- FTCI Technology
- Exchange
- ACET Nasdaq
- FTCI Nasdaq
- Market Cap
- ACET 61.2M
- FTCI 58.9M
- IPO Year
- ACET N/A
- FTCI 2021
- Fundamental
- Price
- ACET $0.76
- FTCI $5.05
- Analyst Decision
- ACET Buy
- FTCI Buy
- Analyst Count
- ACET 6
- FTCI 4
- Target Price
- ACET $6.00
- FTCI $5.50
- AVG Volume (30 Days)
- ACET 406.7K
- FTCI 58.5K
- Earning Date
- ACET 08-12-2025
- FTCI 08-07-2025
- Dividend Yield
- ACET N/A
- FTCI N/A
- EPS Growth
- ACET N/A
- FTCI N/A
- EPS
- ACET N/A
- FTCI N/A
- Revenue
- ACET N/A
- FTCI $55,571,000.00
- Revenue This Year
- ACET N/A
- FTCI $102.41
- Revenue Next Year
- ACET N/A
- FTCI $154.53
- P/E Ratio
- ACET N/A
- FTCI N/A
- Revenue Growth
- ACET N/A
- FTCI N/A
- 52 Week Low
- ACET $0.45
- FTCI $1.76
- 52 Week High
- ACET $1.70
- FTCI $7.40
- Technical
- Relative Strength Index (RSI)
- ACET 57.89
- FTCI 61.58
- Support Level
- ACET $0.58
- FTCI $4.51
- Resistance Level
- ACET $0.82
- FTCI $5.15
- Average True Range (ATR)
- ACET 0.04
- FTCI 0.34
- MACD
- ACET 0.01
- FTCI -0.02
- Stochastic Oscillator
- ACET 74.79
- FTCI 83.33
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.